Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

LinkDoc Raises $103 Million for Oncology AI/Big Data Services
Tianjin JuveStar Enters $74 Million Deal with Raziel for Body Fat Treatment
I-Mab and MorphoSys to Test C5aR1 Antibody in the US
Zai Lab Conducting $845 Million IPO in Hong Kong
XWPharma Completes $40 Million Round for Neurobiology Candidates
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020